188 related articles for article (PubMed ID: 6398630)
1. Methotrexate. II. Use in pediatric chemotherapy.
Lippens RJ
Am J Pediatr Hematol Oncol; 1984; 6(4):397-413. PubMed ID: 6398630
[TBL] [Abstract][Full Text] [Related]
2. Weekly methotrexate-calcium leucovorin rescue: effect of alkalinization on nephrotoxicity; pharmacokinetics in the CNS; and use in CNS non-Hodgkin's lymphoma.
Pitman SW; Frei E
Cancer Treat Rep; 1977 Jul; 61(4):695-701. PubMed ID: 18282
[TBL] [Abstract][Full Text] [Related]
3. High-dose methotrexate-citrovorum factor rescue in the management of brain tumors.
Djerassi I; Kim JS; Shulman K
Cancer Treat Rep; 1977 Jul; 61(4):691-4. PubMed ID: 301782
[No Abstract] [Full Text] [Related]
4. [Effects of a massive dosage of methotrexate and leucovorin rescue therapy on acute leukemia and malignant lymphoma].
Gan To Kagaku Ryoho; 1982 Mar; 9(3):421-32. PubMed ID: 6764106
[TBL] [Abstract][Full Text] [Related]
5. High-dose methotrexate with citrovorum factor rescue for the treatment of central nervous system tumors in children.
Rosen G; Ghavimi F; Nirenberg A; Mosende C; Mehta BM
Cancer Treat Rep; 1977 Jul; 61(4):681-90. PubMed ID: 301781
[TBL] [Abstract][Full Text] [Related]
6. [Therapy of solid tumors using high-dose methotrexate and citrovorum factor].
Baumgartner G; Heinz R; Karrer K; Pridun N; Lutz D
Osterr Z Onkol; 1977; 3(5-6):141-8. PubMed ID: 300863
[TBL] [Abstract][Full Text] [Related]
7. [Studies on high-dose methotrexate with citrovorum factor rescue therapy in children: analysis of bone marrow cell kinetics by flow cytometry].
Tsurusawa M; Sasaki K; Matsuoka H; Katano N; Fujimoto T
Gan To Kagaku Ryoho; 1985 Sep; 12(9):1827-32. PubMed ID: 3876075
[TBL] [Abstract][Full Text] [Related]
8. Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinoma.
Edelman MJ; Meyers FJ; Houston J; Lauder I
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-68-S15-71. PubMed ID: 9346226
[TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacology of intrathecal methotrexate. II. An improved dosage regimen derived from age-related pharmacokinetics.
Bleyer AW
Cancer Treat Rep; 1977 Nov; 61(8):1419-25. PubMed ID: 579164
[TBL] [Abstract][Full Text] [Related]
10. [Experiences with enterally and parenterally applied leucovorin following therapy with high doses of methotrexate in malignant tumors (author's transl)].
Vahrson H; Gorges K
Med Klin; 1976 Oct; 71(41):1720-3. PubMed ID: 1086422
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of high-dose methotrexate with citrovorum factor rescue.
Isacoff WH; Morrison PF; Aroesty J; Willis KL; Block JB; Lincoln TL
Cancer Treat Rep; 1977 Dec; 61(9):1665-74. PubMed ID: 304376
[TBL] [Abstract][Full Text] [Related]
12. Treatment of mycosis fungoides lymphoma: effectiveness of infusions of methotrexate followed by oral citrovorum factor.
McDonald CJ; Bertino JR
Cancer Treat Rep; 1978 Jul; 62(7):1009-14. PubMed ID: 308391
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections.
Shapiro WR; Young DF; Mehta BM
N Engl J Med; 1975 Jul; 293(4):161-6. PubMed ID: 806016
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of central nervous system leukemia in acute childhood leukemia. I. Results of intrathecal single or multiple drug combination therapy (author's transl)].
Fujimoto T; Hasegawa K; Shin H; Kishida K; Take H
Rinsho Ketsueki; 1975 Dec; 16(12):1109-16. PubMed ID: 1243683
[No Abstract] [Full Text] [Related]
15. High-dose methotrexate with citrovorum factor rescue: predictive value of serum methotrexate concentrations and corrective measures to avert toxicity.
Nirenberg A; Mosende C; Mehta BM; Gisolfi AL; Rosen G
Cancer Treat Rep; 1977 Aug; 61(5):779-83. PubMed ID: 302143
[No Abstract] [Full Text] [Related]
16. [High dose methotrexate with leucovorin rescue in the treatment of malignant lymphoma].
Sampi K; Hattori M
Gan To Kagaku Ryoho; 1982 Jul; 9(6):1068-73. PubMed ID: 6985194
[TBL] [Abstract][Full Text] [Related]
17. A pharmacokinetic model for predicting the concentration of methotrexate in plasma subsequent to intrathecal injection.
Ramu A; Fusner JE
Isr J Med Sci; 1979 Jun; 15(6):494-9. PubMed ID: 582316
[TBL] [Abstract][Full Text] [Related]
18. [l-folinic acid versus racemic folinic acid in the treatment of leukemia in children with high dose of methotrexate].
Etienne MC; Thyss A; Bertrand Y; Rubie H; Milano G
Bull Cancer; 1993 Apr; 80(4):357-63. PubMed ID: 8173189
[TBL] [Abstract][Full Text] [Related]
19. High-dose methotrexate with folinic acid rescue.
Bender JF; Grove WR; Fortner CL
Am J Hosp Pharm; 1977 Sep; 34(9):961-5. PubMed ID: 333910
[TBL] [Abstract][Full Text] [Related]
20. High-dose methotrexate in childhood all.
Moe PJ; Holen A
Pediatr Hematol Oncol; 2000 Dec; 17(8):615-22. PubMed ID: 11127393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]